HROW - Harrow, Inc.

Across the last three months, Harrow, Inc.'s insiders have reduced their positions by a net 11,250 shares worth roughly $450K.

HROW sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Opaleye Management Inc.	3.68M	$146.05M	-
CEO	Baum Mark L	3.00M	$90.48M	-
CFO	Boll Andrew R.	814.7K	$24.36M	-
Dir	Graves Adrienne L	1.0K	$31.1K	-
Dir	Silvernail Lauren P	1.0K	$31.0K	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 14, 2026	Shojaei Amir	Chief Scientific Officer	Sale+OE	11,250	$40.00	$450,000.00	-	-	-
May 18, 2026	Graves Adrienne L	Director	Buy	1,000	$31.07	$31,070.00	New	+27.8%	-
May 18, 2026	Silvernail Lauren P	Director	Buy	1,000	$31.00	$31,000.00	New	+27.8%	-
May 14, 2026	Boll Andrew R.	President and CFO	Buy	3,500	$29.90	$104,650.00	+0.4%	+27.5%	-
May 14, 2026	Baum Mark L66	Chief Executive Officer	Buy	10,000	$30.20	$302,000.00	+0.3%	+27.5%	-
Mar 4, 2026	Opaleye Management Inc.60	10% Owner	Sell	198,572	$39.51	$7,846,425.65	-5.1%	-16.2%	-
Feb 27, 2026	Opaleye Management Inc.60	10% Owner	Sell	5,000	$54.18	$270,900.00	-7.1%	-34.7%	-
Jan 6, 2026	Opaleye Management Inc.60	10% Owner	Sell	20,000	$53.35	$1,066,914.00	-22.2%	-34.3%	-
Jun 10, 2025	Opaleye Management Inc.60	10% Owner	Sell	30,204	$30.59	$923,827.13	-25.1%	+27.6%	-
Jun 4, 2025	Opaleye Management Inc.60	10% Owner	Sell	4,796	$30.03	$144,023.58	-3.8%	+27.8%	-